Maternus-Kliniken Aktiengesellschaft (ETR:MAK)
0.9600
+0.0050 (0.52%)
At close: Feb 13, 2026
ETR:MAK Market Cap
ETR:MAK has a market cap or net worth of €20.13 million as of February 13, 2026. Its market cap has decreased by -44.83% in one year.
Market Cap
20.13M
Enterprise Value
19.50M
Revenue
116.17M
Ranking
n/a
PE Ratio
n/a
Stock Price
€0.96
Market Cap Chart
Since February 17, 1998, ETR:MAK's market cap has decreased from 110.87M to 20.13M, a decrease of -81.84%. That is a compound annual growth rate of -5.91%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 13, 2026 | 20.13M | -5.88% |
| Dec 30, 2025 | 21.39M | -25.00% |
| Dec 30, 2024 | 28.52M | -52.45% |
| Dec 29, 2023 | 59.97M | 71.26% |
| Dec 29, 2022 | 35.02M | -65.64% |
| Dec 30, 2021 | 101.91M | 10.96% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Merck KGaA | 55.56B |
| Siemens Healthineers AG | 45.39B |
| Bayer Aktiengesellschaft | 45.18B |
| Fresenius SE & Co. KGaA | 28.53B |
| Cantourage Group SE | 51.25M |
| Pentixapharm Holding AG | 48.03M |
| MeVis Medical Solutions AG | 45.14M |
| aap Implantate AG | 21.14M |